Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Biosynex

Market Cap 1.68Cr 1.94Cr 1.55Cr 1.45Cr 2.71Cr 184.59Cr 2.75Cr 18Cr 7.12Cr 90Cr 7.29Cr 7.13Cr 311.09Cr P/E Ratio 2024
-0.43x
P/E Ratio 2025 -0.19x
Enterprise Value 7Cr 8.1Cr 6.45Cr 6.03Cr 11Cr 769.95Cr 11Cr 76Cr 30Cr 374.76Cr 30Cr 30Cr 1.3TCr EV / Sales 2024
0.71x
EV / Sales 2025 0.68x
Free-Float
40.35%
Yield 2024 *
-
Yield 2025 -
1 day-1.09%
1 week-2.15%
Current month-13.33%
1 month-16.51%
3 months+6.56%
6 months+90.78%
Current year+52.68%
1 week 0.91
Extreme 0.91
0.98
1 month 0.88
Extreme 0.878
1.22
Current year 0.56
Extreme 0.564
1.57
1 year 0.46
Extreme 0.455
1.57
3 years 0.46
Extreme 0.455
11
5 years 0.46
Extreme 0.455
28.78
10 years 0.46
Extreme 0.455
30.38
Manager TitleAgeSince
Chief Executive Officer 71 24/06/2015
Chief Tech/Sci/R&D Officer 63 01/01/2015
Corporate Officer/Principal - -
Director TitleAgeSince
Director/Board Member 63 24/06/2015
Director/Board Member - 24/06/2015
Chairman 71 24/06/2015
Date Insider Type Main position Quantity % Market Cap.
15/23/15Buy

Director

2,500 0.0244%
15/23/15Buy

Director

2,500 0.0244%
28/22/28Buy

Chief Executive Officer

2,500 0.0225%
Change 5-day change 1-year change 3-year change Capi.($)
-1.09%-2.15%-28.91%-90.41% 1.94Cr
+0.55%+4.78%+167.03%+249.59% 1.75TCr
-1.74%-7.00%-43.82%-25.79% 925.25Cr
+0.19%+3.51%+34.29%+21.62% 680.49Cr
-0.17%+8.98% - - 507.98Cr
-0.39%-2.02%-27.97%-27.14% 506.01Cr
-2.92%-6.89%-28.74%-31.75% 408.08Cr
-1.36%-13.84%+68.37%+62.62% 376.59Cr
-0.72%-7.09%+176.91%-50.20% 366.14Cr
+0.64%+0.51%-16.55%-41.45% 263.97Cr
Average -0.70%-1.53%+33.40%+7.45% 578.17Cr
Weighted average by Cap. -0.45%-0.15%+63.43%+74.68%

Financials

2024 2025
Net sales 10Cr 12Cr 9.32Cr 8.73Cr 16Cr 1.11TCr 17Cr 110.08Cr 43Cr 541.91Cr 44Cr 43Cr 1.88TCr 9.52Cr 11Cr 8.77Cr 8.21Cr 15Cr 1.05TCr 16Cr 103.58Cr 40Cr 509.91Cr 41Cr 40Cr 1.77TCr
Net income -4.33Cr -5.02Cr -3.99Cr -3.74Cr -7Cr -476.87Cr -7.11Cr -47Cr -18Cr -232.11Cr -19Cr -18Cr -803.68Cr -5.82Cr -6.74Cr -5.37Cr -5.02Cr -9.41Cr -640.76Cr -9.56Cr -63Cr -25Cr -311.88Cr -25Cr -25Cr -1.08TCr
Net Debt 5.29Cr 6.13Cr 4.88Cr 4.57Cr 8.56Cr 582.56Cr 8.69Cr 58Cr 22Cr 283.56Cr 23Cr 23Cr 981.81Cr 5.32Cr 6.16Cr 4.9Cr 4.59Cr 8.6Cr 585.36Cr 8.73Cr 58Cr 23Cr 284.92Cr 23Cr 23Cr 986.52Cr
Logo Biosynex
Biosynex specializes in the research, development and manufacturing of fast diagnosis tests on membrane support for health professionals (biologists, clinicians, nurses and midwives). Products are used in the tropical diseases, autoimmune diseases, emergency markers and Infectious diseases fields. The company's activity is organized around 5 areas: - manufacturing of diagnosis tests for own account; - sale of diagnosis tests supplied by other manufacturers of semi-finished products; - research and development services for third party; - sale of licenses; - sale of biological reagents.
Employees
397
Date Price Change Volume
12/26/12 0.9100 -1.09% 8,629
11/26/11 0.9200 -4.56% 6,788
10/26/10 0.9640 +2.55% 6,212
09/26/09 0.9400 -0.63% 6,009
08/26/08 0.9460 +1.72% 4,647
  1. Stock Market
  2. Stocks
  3. ALBIO Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!